May 1st, 2012

Robotic Surgery Is Useful Option for Oral Cancer

By

Minimally invasive transoral robotic surgery (TORS), used alone or combined with adjuvant therapy, provides good functional and oncologic outcomes in patients with oropharyngeal squamous cell carcinoma (OPSCC), new research suggests. The results were especially impressive in patients with human papillomavirus (HPV) infection, which is currently the most common cause of OPSCC in Europe and the United States. Eric J. Moore, MD, associate professor of Otolaryngology at the Mayo Clinic in Rochester, Minnesota, and coauthors reviewed a prospective database of patients with previously untreated OPSCC arising in the tonsil or base of the tongue who underwent TORS at their institution during a recent 2-year period.

 

OncLive by Jill Stein

Tags: Dr. Eric J. Moore, HPV, Infectious Diseases, Mayo Clinic Rochester, OncLive, OPSCC, Research, transoral robotic surgery

Contact Us · Privacy Policy